Joyce Meghan V. sold $83K of GH
Joyce Meghan V. sold 650 shares of Guardant Health, Inc. (GH) at $128.02 on 2026-06-03 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
A director’s open-market sale of 650 shares (total ~$83.2K) under a 10b5-1 plan is generally not a fundamental trigger; traders may still monitor for clustering of insider sales versus buys.
Market read
Primarily a sentiment/positioning datapoint; no new operational, financial, or regulatory catalyst is provided.
What to watch
The filing does not indicate whether other insiders/funds are buying or selling around the same time, so broader ownership flow is not captured here.
Background
The article is an SEC EDGAR Form 4 disclosure of an insider transaction for Guardant Health, Inc.
Ticker impact
Guardant Health director Joyce Meghan V. sold 650 shares in an open-market transaction under a pre-arranged 10b5-1 plan, disclosed via Form 4.
Low likelihood of a sustained price move; any impact is likely short-lived and sentiment-driven.
Insider sales on 10b5-1 plans are typically pre-scheduled and not strong standalone signals; the article provides no new company-specific catalyst beyond the transaction details.
Market effects
Minimal; this is company-specific insider activity with no sector-wide catalyst described.
None indicated; US-listed issuer filing only.
None indicated; no international transaction or regulatory action mentioned.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect liquidity/portfolio management rather than bearish expectations.
Key entities
- issuerGuardant Health, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderJoyce Meghan V.
Director who sold 650 shares on 2026-06-03 under a pre-arranged 10b5-1 plan.
